H-CYTE, Inc.
Save
624.98K
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
Similar securities
Based on sector and market capitalization
Report issue